Menu

Breakthrough in the Treatment Of Hepatitis C:

FDA Approves Two New Drugs

In May, the FDA approved the drugs boceprevir (Victrelis) and telaprevir (Incivek) in the fight to treat Hepatitis C, affecting over 4 million Americans. FDA director, Dr. Edward Cox, said in a statement. "The availability of new therapies that significantly increase responses while potentially decreasing the overall duration of treatment is a major step forward in the battle against chronic hepatitis C infection."

Read more.

Testimonials

  • "Doctor McClendon was really helpful, knowledgeable, and friendly. I'm really impressed with this clinic. Thank you. Front desk staff was really helpful and respectful as well."
    ErinB V
  • "Dr. Molloy's staff has always gone above and beyond to help expedite my care and referrals. Keep up the great work!"
    Dan R
  • "From my first phone call to his office and subsequent video conferencing with Dr. McClendon did I realize that I had got the right Doctor. My interaction with his staff and him were amazing. For a person that is anxious and reluctant to go to doctors, they made me feel at ease."
    Tim F